As of close of business last night, Tempest Therapeutics Inc’s stock clocked out at $3.68, down -0.81% from its previous closing price of $3.71. In other words, the price has decreased by -$0.0300 from its previous closing price. On the day, 602503 shares were traded. TPST stock price reached its highest trading level at $3.8500 during the session, while it also had its lowest trading level at $3.5400.
Ratios:
To gain a deeper understanding of TPST’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.66 and its Current Ratio is at 1.66.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Jefferies on February 08, 2024, initiated with a Buy rating and assigned the stock a target price of $15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TPST now has a Market Capitalization of 70.83M and an Enterprise Value of 80.72M.
Stock Price History:
Over the past 52 weeks, TPST has reached a high of $9.77, while it has fallen to a 52-week low of $0.17. The 50-Day Moving Average of the stock is 4.0592, while the 200-Day Moving Average is calculated to be 2.4728.
Shares Statistics:
It appears that TPST traded 918.65K shares on average per day over the past three months and 438.38k shares per day over the past ten days. A total of 19.25M shares are outstanding, with a floating share count of 15.99M. Insiders hold about 16.90% of the company’s shares, while institutions hold 9.26% stake in the company. Shares short for TPST as of Feb 15, 2024 were 870.37k with a Short Ratio of 0.95, compared to 554.32k on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 4.52% and a Short% of Float of 5.90%.
Earnings Estimates
As of right now, 5 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.32 and a low estimate of -$0.43, while EPS last year was -$0.63. The consensus estimate for the next quarter is -$0.38, with high estimates of -$0.26 and low estimates of -$0.55.
Analysts are recommending an EPS of between -$1.83 and -$2 for the fiscal current year, implying an average EPS of -$1.94. EPS for the following year is -$1.45, with 5 analysts recommending between -$0.83 and -$2.07.
